|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 333/22 | |
| C07D 333/24 | |||
| C07D 409/10 | |||
| C07D 333/12 | |||
| C07D 333/20 |
| (11) | Patento numeris | 3148979 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15798804.9 |
| Europos patento paraiškos padavimo data | 2015-05-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-02-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/053780 |
| Data | 2015-05-22 |
| (87) | Numeris | WO 2015/181692 |
| Data | 2015-12-03 |
| (30) | Numeris | Data | Šalis |
| 1766MU2014 | 2014-05-27 | IN |
| (72) |
BHIRUD, Shekhar Bhaskar, IN
NAIK, Samir, IN
SRIVASTAVA, Sachin, IN
DEORE, Dinesh, IN
SINHA, Sukumar, IN
|
| (73) |
Glenmark Pharmaceuticals Limited,
Glenmark House HDO-Corporate Bldg. Wing A, B.D. Sawant Marg Chakala, Andheri (East), Mumbai 400 099,
IN
|
| (54) | PROCESS FOR PREPARATION OF CANAGLIFLOZIN |
| PROCESS FOR PREPARATION OF CANAGLIFLOZIN |